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Abstract Induced pluripotent stem cells (iPSCs) hold great promise for regener-
ative medicine and disease modeling. The original methods to grow human iPSCs
utilized methods developed for human embryonic cells (ESCs), in which mitoti-
cally inactivated mouse-derived fibroblasts are mainly used as a “feeder” cell layer
to maintain the undifferentiated status of pluripotent stem cells. However, these
methods still require further consideration to facilitate cell expansion and to
maintain the undifferentiated state of human iPSCs and/or ESCs for a longer period
of time. In addition, the use of animal-derived feeders should be avoided for
eventual clinical application of iPSC therapies. Therefore, human-derived feeder
culture systems or feeder-free culture systems are currently being developed to
prevent exposure to animal pathogens. In this review, existing mouse and human
feeder culture systems for human ESCs and iPSCs are first introduced, and then
previously reported feeder-free culture methods using extracellular matrix-
associated products or synthetic biomaterials are outlined to discuss an appropriate
culture system for clinical application of iPSCs.
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Human induced pluripotent stem cells (iPSCs) generated by the introduction of
defined factors from somatic cells exhibit pluripotency similar to that of human
embryonic stem cells (ESCs) [1]. The iPSC technology offers great promise for
regenerative therapies and disease modeling in both the medical and dental fields
[2]. iPSCs have pluripotency to differentiate into almost all cell types and superior
self-renewal capacity that enables unlimited expansion [3], which has prompted
researchers to apply them as a cell source for transplantation therapies to regenerate
various types of missing, diseased, or defective tissues/organs. However, before
iPSCs can be used in the transplantation therapy, several technical limitations of the
culture methods must be addressed. For instance, human ESCs and iPSCs cannot
sustain their original characteristics in monoculture on standard tissue culture plates
without supporting factors. In an in vitro culture system, human ESCs/iPSCs
typically require “feeder cells”, which produce specific stemness-supporting fac-
tors, to prevent spontaneous differentiation [4, 5]. Feeder cells also produce adhe-
sion molecules and extracellular matrix (ECM) to improve ESC/iPSC attachment,
thereby supporting the growth and survival of ESCs/iPSCs. The most commonly
used feeder cells are mitotically inactivated mouse-derived fibroblasts [4, 6–8];
however, these animal-derived feeder cells pose an increased risk of transferring
unknown viruses and zoonotic pathogens in addition to immune rejection. Alter-
natively, human-derived cells have also been shown to effectively function as
feeder cells for ESCs/iPSCs. Furthermore, “feeder-free” culture systems, such as
culture using cell-free ECM proteins or synthetic biomaterials as substrates, have
recently received increasing attention. This review assesses various ESC/iPSC
culture methods with regard to feeder cells and feeder-free methods to help identify
an appropriate culture condition for future clinical applications of iPSCs.
12.2 Feeder Cells for ESC/iPSC Culture
12.2.1 Mouse-Derived Feeder Cells
Since mouse ESCs were first established in 1981 [9, 10], mitotically inactivated
fetal mouse fibroblasts have been used as feeder cells for mouse ESC culture. This
feeder culture method developed for mouse ESCs was applied to human ESCs
when Thomson group first established human ESC lines in 1998 [4], showing that
mouse feeder cells could be used to facilitate proliferation and prevent differenti-
ation of human ESCs. Subsequently, several types of mouse-derived feeder cells
have been used in human ESC/iPSC studies, such as mouse embryonic fibroblasts
(MEFs), STO cells, and SNL 76/7 cells.
MEFs are the most commonly used feeder cells used to support the pluripotent
status of human ESC cultures [4, 11, 12]. Primary MEFs are not homogeneous, as
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they contain several types of cells other than fibroblasts [13]. To maintain ESC
proliferation and pluripotency, MEFs produce various proteins, including
transforming growth factor beta 1 (TGF-β1), activin A, bone morphogenetic protein
(BMP)-4 [14], and pleiotrophin (heparin-binding growth factor) [15]. When used as
in feeder cell layers, MEFs are proliferation-inactivated by chemical (mitomycin C)
treatment or gamma irradiation prior to seeding of ESCs/iPSCs. It should be noted
that the mitotic inactivation or irradiation of MEFs stimulates the expression of
several signaling proteins, such as Wnt-3 [16], which may participate in the
molecular mechanisms underlying the maintenance of pluripotency in co-cultured
human ESCs/iPSCs. The outbred mouse CF-1 strain may be the most widely used
donor for MEF feeder cells for ESC and iPSC culture [13, 17], as CF-1 MEFs have
been shown to produce TGF-β1, activin A, BMP-4, gremlin, and noggin [14, 18,
19] but not bFGF [14]. One disadvantage of using primary MEFs is their limited
proliferation capacity, which requires repeated isolation from embryonic mice to
supply feeder cells [20]. In addition, repeated passaging causes MEFs to lose their
capacity to support the proliferation of ESCs/iPSCs [21]. To solve this problem,
Choo et al. [22] generated an immortalized primary MEF line (ΔE-MEF) through
infection with retrovirus vectors encoding the E6 and E7 genes from human
papillomavirus (DNA tumor virus) and demonstrated the consistent and reproduc-
ible feeder capacity of these cells for hESC culture.
STO cells were isolated by Bernstein from Sandoz inbred mouse (SIM)-derived
fibroblasts as a thioguanine- and ouabain-resistant sub-line [13]. STO cells are more
easily maintained than MEFs for preparation of feeder layers because STO cells are
a spontaneously transformed cell line. In 1998, Shamblott et al. [23] showed that
STO cells can be used in a feeder layer for establishing of human embryonic germ
cells. In 2003, Park et al. [20] first demonstrated that STO cells have the potential to
support the establishment and maintenance of human ESC lines. Thereafter, STO
cells have been widely used as feeder cells for human ESC and iPSC culture
[24, 25]. Proteome analyses have revealed that STO cells produce unique protein
species, such as insulin-like growth factor binding protein 4 (IGFBP-4), pigment
epithelium-derived factor (PEDF) and secreted protein acidic and rich in cysteine
(SPARC, also known as osteonectin), which may be associated with differentiation
and cell growth [26]. Talbot et al. [17] showed from quantitative immunoassays that
STO cells express lower levels of activin A, interleukin-6, IGFBP-2, IGFBP-3,
IGFBP-4, and IGFBP-5 than CF-1 cells but higher levels of hepatocyte growth
factor (HGF) and stem cell factor (c-kit ligand). The difference in the growth factor
production among feeder cell types may result in different abilities to support the
growth of undifferentiated human ESCs/iPSCs. Indeed, conditioned media from
primary MEF cultures but not STO cell cultures support the undifferentiated status
of human ESCs on Matrigel- or laminin-coated culture plates [27]. One of the main
mechanisms by which STO cells support ESC/iPSC pluripotency appears to be
laminin expression because laminin on the STO cell surface interacts with specific
receptors (integrin α6, β1 dimer) on human ESCs to maintain their undifferentiated
status [20]. Therefore, compared to MEFs, STO feeder cells may require more
direct cell contact with human ESCs/iPSCs to support pluripotency.
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SNL76/7 cells were clonally derived by Bradley [28] from STO cells
transformed with neomycin resistance and murine leukemia inhibitory factor
(LIF) genes. SNL76/7 cells abundantly express the pleiotropic cytokine LIF,
which promotes long-term maintenance of mouse ESCs by suppressing spontane-
ous differentiation [29]. In contrast to the case with mouse ESCs, LIF does not
satisfactorily support the self-renewal of human ESCs [4]. Nonetheless, SNL76/7
cells basically inherit the nature of STO cells; therefore, SNL 76/7 cells can be used
as feeder cells for both mouse [6, 30, 31] and human [1, 28, 30] ESCs/iPSCs.
Bradley also established a puromycin-resistant derivative of SNL76/7 cells
(SNLP76/7-4 cell line: Fig. 12.1) that is useful for drug selection of transfected
ESCs/iPSCs [32]. An immortalized mouse fetal liver stromal cell line (KM3 cells)
was also reported to support the growth and maintenance of human ESCs when
co-cultured in with the ESCs in a feeder cell layer [33].
These feeder cell lines may be useful for laboratory experiments because they
enable large-scale expansion of human ESCs/iPSCs at low cost; however, it is
important to note that mouse feeder methods are associated with a high possibility
of contamination by the feeder cells during human ESC/iPSC isolation. Kim
et al. [34] described a unique and less labor-intensive method to reduce contami-
nation by feeder cells by culturing human ESCs on porous membranes of transwell
inserts that have mouse feeder cells attached to the other side of the membrane.
12.2.2 Human-Derived Feeder Cells
Although mouse feeder systems are convenient for laboratory experiments, such
xenobiotic support systems are associated with the risk of cross-transfer of animal
pathogens and are thus not favorable for future clinical application of iPSCs. To
solve this problem, many studies to date have demonstrated the utility of human-
derived cells as feeders for human ESCs and iPSCs (Table 12.1).
Fig. 12.1 (Left) Mouse-derived SNL76/7 cells. (Right) Undifferentiated human iPSC colonies on
the SNLP76/7-4 feeder cells
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Primary human foreskin fibroblasts (FFs), which can easily be prepared from
infant foreskin, are among the most frequently used human feeder cells for ESCs
and iPSCs [35, 37–44]. Similar to primary MEF cells, human FF feeder cells show
limited expansion in culture; therefore, fresh batches of FFs have to be prepared on
a routine basis. To overcome this drawback, Unger et al. [36] established a
conditionally immortalized human FF line that secreted bFGF and showed that
the generated cells could support the culture of both human ESCs and iPSCs.
Mesenchymal stem cells (MSCs) are easily accessible postnatal human cells that
include bone marrow-derived MSCs (BMSCs) [3]. Culture-expanded BMSCs can
support prolonged expansion of human ESCs in culture [37, 39, 45]. Adipose-
derived stromal cells (ASCs), which are another type of MSCs, also have the ability
to serve as feeder cells for human ESCs/iPSCs [46, 47]. Sugii et al. [58] showed that
ASCs express high levels of bFGF, TGFβ, fibronectin, and vitronectin and can thus
serve as feeder cells for both autologous and heterologous human iPSCs. Because
ASCs can be easily isolated by surgery or lipoaspiration from adults, their use as
feeder cells is expected to provide an important step toward establishing safe,
clinical-grade human iPSC lines.
Table 12.1 Summary of human feeder cells for human ESC/iPSC culture
Feeder cell sources Cells Culture medium References
Foreskin fibroblasts iPSCs KSR medium [35, 36]
ESCs KSR medium [35–42]
ESCs HEScGRO [43]
ESCs FBS-hES/KSR medium [44]
Bone marrow-derived MSCs ESCs KSR medium [37, 39, 45]
Adipose-derived stromal cells iPSCs mTeSR1 [46]
ESCs KSR medium [47]
iPSCs
Amniotic MSCs ESCs – [48]
Amniotic epithelial cells ESCs KSR medium [49]
ESCs DMEM [50]
iPSCs DMEM–F12 medium [51]
Placental fibroblasts ESCs KSR medium [37]
ESCs X-VIVO 10 [52]
Umbilical cord stromal cells ESCs KSR medium [53]
Transgenic fetal fibroblasts ESCs KSR medium [54]
Fetal muscle cells ESCs H1/H2 medium [55]
Fetal skin cells ESCs H1/H2 medium [55, 56]
Fetal liver stromal cells ESCs KSR medium [57]
MSCsmesenchymal stem cells, ESCs embryonic stem cells, iPSCs induced pluripotent stem cells,
KSR KnockOut™ Serum Replacement, HEScGRO medium animal-component-free medium
(Millipore), FBS fetal bovine serum, hES medium standard human ESC culture medium,
mTeSR1 chemically defined xeno-free human ESC culture medium (Stemcell Technologies),
DMEM Dulbecco’s modified Eagle medium, X-VIVO 10 chemically defined and serum-free
medium (Lonza)
12 Feeder Cell Sources and Feeder-Free Methods for Human iPS Cell Culture 149
The amniotic fluid contains MSCs that are easily obtained and relatively exempt
from ethical problems. Zhang et al. [48] reported that human amniotic MSCs can be
used as feeder cells for effective growth of human ESCs. Human amniotic epithelial
cells (AECs) can be isolated from the surface membrane of fresh placentas, and
they express many growth factors including EGF, bFGF, TGF-β, and BMP-4 [49,
59, 60] in addition to stem cell markers such as Oct-4 and Nanog [50]. Additionally,
Liu et al. [51] recently showed that microRNA-145-mediated regulation of Sox2
expression in human AECs maintains the self-renewal and pluripotency of human
iPSCs. Human placental fibroblasts also showed comparable or superior efficacy to
MEFs as feeder cells for human ESCs [37, 52]. Because the human placenta and
amnion are discarded as medical waste, they may be promising tissue sources for
human feeder cells for iPSCs. Umbilical cord stromal cells, which can be obtained
through noninvasive procedures, also support the self-renewal of human ESCs in
serum-free conditions [53]; therefore, they may be still another promising source of
human feeder cells for iPSC culture.
Other previously reported human feed cells for ESC/iPSC culture include dermal
fibroblasts [61], adult fallopian tube epithelial cells [55], adult lung cells [56],
transgenic (puromycin resistant) fetal fibroblasts [54], fetal muscle cells [55],
fetal skin cells [55, 56], and fetal liver stromal cells [57]. However, although
these human feeder cells can be used in laboratory experiments, they are not
suitable for clinical use because the harvesting of the source tissue is invasive
and may pose ethical issues.
Nearly all human feeder cells require supplementation with bFGF to sustain
human ESC/iPSC potential; therefore a bFGF-dependent pathway may be crucial
for maintaining the pluripotency of human pluripotent stem cells. Park et al. [37]
evaluated the feeder ability of several types of human feeder cells (placental cells,
BMSCs, and FFs) and showed that these cells support the undifferentiated growth
of human ESCs through bFGF synthesis. In contrast, Bendall et al. [62] demon-
strated that human ESCs autologously produce fibroblast-like cells around their
colonies that act as a supportive niche for the survival and self-renewal of human
ESCs through IGF-II production in response to bFGF.
12.3 Feeder-Free Methods for ESC/iPSC Culture
To achieve reliable and safe production of human iPSCs, it is desirable to use
reagents that are defined, qualified, and preferably derived from a non-animal
source. Although the use of human feeder cells circumvents the use of animal-
derived feeder cells, the function of the feeder cells in the human iPSC co-culture
system is still not fully understood. In addition, the preparation of the feeder cells is
highly laborious, which limits the large-scale production of human iPSCs for future
clinical applications. Therefore, development of feeder-free human iPSC culture
systems has been an important focus of recent iPSC research.
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12.3.1 ECM-Related Materials
The ECM is a uniquely assembled three-dimensional (3-D) molecular complex that
varies in composition and diversity, and consists of basic components such as
laminin, fibronectin, vitronectin collagen, cadherin, elastin, hyaluronic acid, and
proteoglycans. In the absence of feeder cells, human ESCs/iPSCs require attach-
ment factors to promote their survival and proliferation. In this regard, the ECM and
its soluble factors support the adhesion, growth, and maintenance of ESCs/iPSCs.
To date, various ECM-related materials have been evaluated as a substitute for
feeder cells for human pluripotent stem cell culture (Table 12.2).
12.3.1.1 ECM Components
Matrigel™ [27, 63, 64], which is a commercially available protein mixture extracted
from the Engelbreth-Holm-Swarm mouse tumor [73], is one of the most frequently
used matrices for feeder-free growth of undifferentiated human pluripotent stem
cells. Matrigel™ contains a complex and poorly defined mixture of fibronectin,
laminin, type IV collagen, entactin, and heparan sulfate proteoglycans, in addition
to various growth factors such as bFGF, EGF, PDGF, NGF, and TGF-β. To
maintain human ESCs/iPSCs in an undifferentiated state, Matrigel™-coating
requires soluble stemness-supporting factors produced by MEFs or other feeder
cells (conditioned medium) [27]. Despite its availability and ease of use, Matrigel™
Table 12.2 Summary of extracellular matrix-related biomaterials for feeder-free human
ESC/iPSC culture
Matrix/biomaterial Cells Culture medium References
Matrigel™ ESCs hES medium [27, 63, 64]
MEF-CM
Human MSC-derived matrix ESCs SBX medium [65]
Human serum ESCs hES-dF-CM [66]
Laminin ESCs hES medium [27, 67]
MEF-CM
NC-SFM
Recombinant laminin E8 fragments ESCs/iPSCs mTeSR1 [68]
Fibronectin ESCs KSR medium [69]
Vitronectin ESCs mTeSR1 [70]
Collagen (type 1) ESCs mTeSR1 [71]
Hyaluronic acid hydrogels ESCs MEF-CM [72]
MSCsmesenchymal stem cells, ESCs embryonic stem cells, iPSCs induced pluripotent stem cells,
hES medium standard human ESC culture medium,MEF-CMmouse embryonic fibroblast-derived
conditioned medium, SBX medium chemically defined xeno-free medium, hES-dF-CM condi-
tioned medium of fibroblasts derived from differentiated human ESCs, NC-SFM non-conditioned
serum-free medium, KSRKnockOut™ Serum Replacement,mTeSR1 chemically defined xeno-free
human ESC culture medium (Stemcell Technologies)
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is not ideal for potential clinical application of human iPSCs because it is animal-
derived and xenogenic pathogens can be transmitted through culture even though
no feeder cells are present. However, Peiffer et al. [65] demonstrated that matrices
derived from human MSCs could advantageously replace MEF or hMSC feeder
cells. Furthermore, human serum can be also used as a matrix to support the
undifferentiated growth of human ESCs [66].
12.3.1.2 Recombinant ECM Products
Human ESCs express integrin receptors for major ECM proteins (laminin, fibro-
nectin, collagen, and vitronectin) and all of these receptors functionally mediate
cell adhesion [70]. Laminin, which is a major component of the ECM of all basal
laminae in vertebrates, can support the pluripotency of human ESCs when used
together with the conditioned medium of MEFs [27]. The MEF conditioned
medium can also be replaced, however, as the combination of a human laminin
coating with defined medium supplements, such as recombinant bFGF and the
additional growth factors flt3-L, SCF, and LIF, was shown to support the growth
and maintenance of undifferentiated human ESCs [67]. It has also been shown that
recombinant laminin E8 fragments (LM-E8s), which are truncated peptides com-
posed of the C-terminal regions of the α, β, and γ chains of laminin, enable robust
propagation of human ESCs and iPSCs in an undifferentiated state in cultures with
defined and xeno-free media [68]. We have confirmed that human gingiva-derived
iPSCs [30] can be maintained in an undifferentiated state on LM-E8-coated plates
after dissociation and passaging (Fig. 12.2).
Fibronectin, vitronectin, and gelatin (a hydrolyzed product of collagen) are rich
in arginine-glycine-aspartate (RGD) peptide sequences that are required for
integrin-mediated cell adhesion and growth through activation of cellular signaling
pathways [74]. Amit and Itskovitz–Eldor [69] reported that a human fibronectin
coating and medium supplementation with TGFβ and bFGF provide a feeder-free
and serum-free culture system for human ESCs. Vitronectin is the major ECM
protein but is not present in Matrigel™; thus, Braam et al. [70] reported that
recombinant vitronectin was a defined functional alternative to Matrigel™ for
supporting sustained self-renewal and pluripotency of human ESC lines. Liu
et al. [75] also demonstrated that nanofibrous gelatin substrates can provide an
alternative to Matrigel™ for long-term expansion of human ESCs.
Type 1 collagen is the most abundant structural protein of the human body.
Furue et al. [71] reported that a substrate composed only of type I collagen could be
combined with a defined medium supplemented with heparin, bFGF, insulin,
transferrin, and fatty acid-free albumin conjugated with oleic acid for culture of
human ESCs. E-cadherin, a cell adhesion molecule, is essential for intercellular
adhesion [76] and colony formation among mouse ESCs [77]. Nagaoka et al. [78]
generated a fusion protein consisting of human E-cadherin and the IgG Fc domain
and demonstrated that this protein could be substituted for Matrigel™ and could
support the pluripotency of human ESCs and iPSCs under completely defined
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culture conditions. Hyaluronic acid (HA) is an anionic, nonsulfated glycosamino-
glycan that is distributed widely throughout connective, epithelial, and neural
tissues. Gerecht et al. [72] demonstrated that HA-based hydrogels maintain the
undifferentiated state of human ESCs in the presence of conditioned medium
from MEFs.
12.3.2 Synthetic Materials
Although human-sourced and recombinant ECM materials can be used in animal-
component-free and effective culture systems for human ESCs/iPSCs, they are still
associated with high product cost and possible batch-to-batch variation. In contrast,
synthetic biomaterials and chemical coating technologies (Table 12.3) may offer a
fully defined culture system with lower cost and higher consistency.
Because most cells are cultured on tissue culture-treated polystyrene, the devel-
opment of a chemical treatment for standard tissue culture-treated polystyrene is
desirable for a 2-dimensional culture system for ESCs/iPSCs. Along these lines,
Mahlstedt et al. [79] demonstrated that oxygen plasma-etched tissue culture-treated
polystyrene could maintain the pluripotency of human ESCs in MEF conditioned
medium.
However, the 3-D microenvironment has recently been appreciated for its ability
to influence the behavior of pluripotent stem cells. For example, a 3-D porous
Fig. 12.2 Undifferentiated human gingiva-derived iPSC colonies on a recombinant laminin E8
fragment-coated plate (feeder-free culture)
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natural polymer scaffold prepared from a chitosan and alginate complex was
reported to sustain the self-renewal of human ESCs without the support of feeder
cells or conditioned medium [82]. Similarly, Carlson et al. [83] reported the
combination of poly-D-lysine, which is a synthetic positively charged amino acid
chain commonly used as a coating to enhance cell adhesion, with synthetic polymer
scaffolds with a 3-D fibrous architecture promote the adhesion, proliferation, and
self-renewal of human ESCs. Additionally, microcarrier particles have also been
used as substrates to amplify various types of adherent cells [84]. In particular,
Phillips et al. [80] showed that seeding on trimethyl ammonium-coated polystyrene
microcarriers enabled feeder-free 3-D suspension and-single cell culture for human
ESCs, thus providing a low-cost, practical feeder-free method for large-scale
human ESC/iPSC production. Furthermore, Siti-Ismail et al. [81] demonstrated
that human ESCs encapsulated in calcium alginate hydrogels could be maintained
in an undifferentiated state for more than 260 days without requiring feeder cells or
passaging.
12.4 Conclusions
Feeder methods and ECM-related/synthetic materials for human ESC culture are
relatively well established in the literature as outline above; however, the appro-
priate methods and materials for human iPSC culture, especially for clinical use,
still need to be established. Most previous ESC/iPSC studies of animal-component-
free methods focused on the growth and maintenance of iPSCs; however, few
studies have focus on the generation and expansion of human iPSCs. Because
iPSCs are generated from one reprogrammed somatic cell, xeno-free methods to
efficiently promote the clonal growth of single human ESCs are necessary. Bigdeli
et al. [85] reported that human ESC lines can be adapted to matrix-independent
growth, even on plastic plates, by using a specified conditioned medium derived
from human embryonic fibroblasts. This finding implies that it may be possible to
develop a more effective defined culture medium that eliminates the need for a




Oxygen plasma-etched tissue culture-treated polystyrene ESCs MEF-CM [79]
hES medium
Trimethyl ammonium-coated polystyrene microcarriers ESCs hES medium [80]
Calcium alginate hydrogels ESCs hES medium [81]
Chitosan and alginate scaffolds ESCs hES medium [82]
Polymer scaffolds/poly-D-lysine ESCs mTeSR1 [83]
ESCs embryonic stem cells, iPSCs induced pluripotent stem cells, MEF-CM mouse embryonic
fibroblast-derived conditioned medium, hES medium standard human ESC culture medium,
mTeSR1 chemically defined xeno-free human ESC culture medium (Stemcell Technologies)
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substrate and thus achieves a feeder-free and xeno-free culture system for iPSCs.
Investigators should therefore accumulate fundamental data for feeder- and xeno-
free culture technologies by using both synthetic substrates and defined culture
medium components. The establishment of cost-effective, easy-to-handle synthetic,
defined, and stable xeno-free culture systems for human iPSCs will expedite the use
of iPSCs in biomedical applications.
Open Access This chapter is distributed under the terms of the Creative Commons Attribution
Noncommercial License, which permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are credited.
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